Education
About Us
Working with TipRanks
Follow Us
Celularity (CELU)
NASDAQ:CELU
CELU Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.00 - $5.22
Previous Close$2.13
Volume115.00K
Average Volume (3M)85.22K
Market Cap
$41.91M
Enterprise Value$264.68M
Total Cash (Recent Filing)$738.00K
Total Debt (Recent Filing)$29.03M
Price to Earnings (P/E)―
Beta3.64
Next Earnings
May 19, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding23,949,228
10 Day Avg. Volume75,425
30 Day Avg. Volume85,224
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)0.90
Price to Sales (P/S)0.00
P/FCF Ratio-7.27
Enterprise Value/Market Cap6.32
Enterprise Value/Revenue1.48
Enterprise Value/Gross Profit5.84
Enterprise Value/Ebitda-0.72
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Celularity News
PremiumCompany Announcements
Celularity Extends Note Maturity with YA II PNPremiumCompany Announcements
Celularity Inc. Advances Placental-Derived Therapies
Ownership Overview
35.62% Insiders
2.57% Mutual Funds
3.62% Other Institutional Investors
56.06% Public Companies and
Individual Investors
CELU FAQ
What was Celularity’s price range in the past 12 months?
Celularity lowest stock price was $1.00 and its highest was $5.22 in the past 12 months.
What is Celularity’s market cap?
Celularity’s market cap is $41.91M.
When is Celularity’s upcoming earnings report date?
Celularity’s upcoming earnings report date is May 19, 2025 which is 30 days ago.
How were Celularity’s earnings last quarter?
Currently, no data Available
Is Celularity overvalued?
According to Wall Street analysts Celularity’s price is currently Overvalued.
Does Celularity pay dividends?
Celularity does not currently pay dividends.
What is Celularity’s EPS estimate?
Celularity’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Celularity have?
Celularity has 23,949,228 shares outstanding.
What happened to Celularity’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Celularity?
Currently, no hedge funds are holding shares in CELU
Celularity Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Bought Shares
Worth $2.5M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.6%
Last 30 Days ▼ 3.9%
Last 30 Days ▼ 3.9%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-46.15%
12-Months-Change
Fundamentals
Return on Equity
-232.51%
Trailing 12-Months
Asset Growth
118.29%
Trailing 12-Months
Company Description
Celularity
Celularity Inc. (NASDAQ: CELU) is a biopharmaceutical company focused on developing innovative, off-the-shelf allogeneic cellular therapies derived from the postpartum placenta. The company operates primarily in the biotechnology and life sciences sectors, with core products and services centered around cellular therapies for cancer, infectious diseases, and degenerative diseases. Celularity leverages its proprietary technology platform to create advanced therapeutics designed to enhance the body's ability to fight disease, with a commitment to improving patient outcomes.
Technical Analysis
Generation Bio
―
Lantern Pharma
―
Repare Therapeutics
―
Shattuck Labs
―
FibroBiologics, Inc.
―